Definitive Contract HHSN272201700074C
Award Date
7/24/17
Potential Completion Date
7/31/18
Potential Value
$225K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Nanocomposix, Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92111, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $1,500,000.00 Firm Fixed Price contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The objective of the contract is to develop cytomegalovirus (CMV) IgG and IgM lateral flow assays required to support a large-scale CMV vaccination trial. Nanocomposix has prior experience providing lateral flow assay devices,...
This is a $225,000.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Nanocomposix, Inc., a manufacturer of engineered nanoparticles. The contract is for the development of "TOPIC 59 DIAGNOSTICS TO ENABLE MALARIA AND NEGLECTED TROPICAL DISEASES". Nanocomposix has previously provided lateral flow assay devices, gold nanoparticles, and research and development...
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a $249,950.00 firm fixed price purchase order to Nanocomposix, Inc. for the development of a Lateral Assay Device. Nanocomposix is a manufacturer of engineered nanoparticles that has previously supported federal contracts for lateral flow assays, vaccines, and diagnostics. The contract is not set aside for any socioeconomic program. Nanocomposix has produced pilot lots for clinical trials...
The Centers for Disease Control and Prevention has awarded a $300,000 firm fixed price purchase order to Nanocomposix, Inc. for lateral flow assay devices. The contract has no set-aside designation and runs through September 2023. Nanocomposix will deliver the requested lateral flow assay products to CDC under this contract. As a manufacturer of engineered nanoparticles located in San Diego, California, Nanocomposix has extensive experience providing lateral flow assays, gold nanoparticles,...
This is a SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract has a firm fixed price of $300,000.00 and is for the development of a point-of-care test to measure antibiotic concentrations in the blood for tuberculosis (TB) treatment. Nanocomposix has prior experience providing products...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The $1,000,000.00 contract is for the development of a product or technology under the SBIR program. As a Phase II award, this indicates the company previously received a Phase I contract for preliminary research and development. The contract has a cost-plus-fixed-fee pricing type and a period of...
This is a $1,000,000.00 Phase II SBIR contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract is for the rapid screening of individual cells using single cell mass spectrometry, supporting the NCI's biomedical research and development efforts. Nanocomposix has previously supported other federal agencies such as the Department of Defense...
This firm fixed price purchase order contract, awarded by the Centers for Disease Control and Prevention (CDC) to Nanocomposix, Inc., is for $150,000.00 and is for research and development under the Small Business Innovation Research (SBIR) program. The contract is not set aside for a specific business type. Nanocomposix is a small business that manufactures engineered nanoparticles and has previously performed prime contracts and subcontractor work for the National Institutes of Health, Food...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Nanocomposix, Inc. The $200,000.00 fixed-price contract is for the development of "Surface Enhanced Fluorescence Nanotags for Ultrasensitive Multiplexed Assay Systems." As a small business manufacturer of engineered nanoparticles, Nanocomposix has previously received prime federal contracts and...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract, valued at $199,981, is for the development of nanoparticle-enabled single cell mass spectrometry technology for the detection of rare cells, under SBIR Topic 266. As a small business, Nanocomposix has been awarded previous prime...